University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 12 of 21
Brain Blood Flow: Age and Gender
NCT02840851
Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers
NCT02926482
A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2
NCT02973022
Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
NCT02461758
EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study
NCT02735382
Improving Balance for Older Adults: Disseminating Tai Chi Fundamentals Through Community Organizations
NCT04447001
Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
NCT02775045
Improving Pulmonary Function Following Radiation Therapy
NCT02843568
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
NCT02837263
Pilot Study of Bisphosphonates for Breast Cancer
NCT02781805
Effect of Soccer Head Gear to Reduce Concussions
NCT02850926
Variable Dead Space Rebreathing Device to Treat Sleep Apnea
NCT03552133
AsthMatic Inflammation and Neurocircuitry Activation (MINA)
NCT02764437
Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans
NCT02800408
Screening in Trauma for Opioid Misuse Prevention
NCT02861976
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin
NCT02677389
Individually Tailored Yoga Program for the Treatment of Chronic Neck and Back Pain
NCT02806323
Fruit And Vegetable Or Recreation Prescriptions for UW-Madison Students
NCT02870322
Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC
NCT02677376
Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition
NCT02843256
Urological Biofeedback Game Software
NCT02758938
Blood Brain Flow and Exercise
NCT02653638
Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)
NCT02926417
Feasibility Trial for Postoperative Wound Surveillance Using Smartphones
NCT02735525
Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
NCT02769806
Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth
NCT02712034
MRI Markers of Outcome After Severe Pediatric TBI
NCT02688660
MRI Biomarkers and Exercise
NCT02729428
Intensive Versus Traditional Voice Therapy
NCT03129880
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma
NCT02652468
Spontaneous Pneumothorax in Children
NCT02573285
Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)
NCT02560389
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
NCT02719821
Paramedic Coached ED Care Transitions to Help Older Adults Maintain Their Health
NCT02520661
UW-CTRI Triple Medication Smoking Cessation Study
NCT02681510
The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease
NCT02461784
System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2
NCT03523663
Study: Manometry With & Without Lidocaine
NCT03349112
The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors
NCT02510430
Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer
NCT02518308
Structural Stability of Carotid Plaque and Symptomatology
NCT02476396
Semi-Recumbent Vibration Therapy in Older Adults
NCT02533063
5Minutes4Myself: A Wellness Program for Caregivers
NCT03771001
The Long-Term Quitting (Smoking Cessation) Study
NCT02564315
Personalized Vitamin D Supplementation in European and African Americans
NCT02362269
E-Cigarettes: Dynamic Patterns of Use and Health Effects
NCT02527980
Feasibility and Dose Tolerability of HD-tDCS in Healthy Adults and Children With Down Syndrome
NCT02481765
A Well-being Training for Preservice Teachers
NCT02544412
Exercise and Treatment-as-usual in Substance Use Treatment Outcomes
NCT02570360
Mindfulness Training for Head Start Parents
NCT02637908
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.